The short version of dihexa fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-01-06. Anything still debated is marked as such rather than presented as settled.
Identity and purity are usually assessed with reverse-phase high-performance liquid chromatography and mass spectrometry. These methods can separate related impurities and confirm molecular mass, but they do not by themselves establish biological activity. Certificate of analysis documents may report purity as a percentage by area, yet the exact meaning can vary between laboratories. Independent testing can check for residual solvents, counterions, or microbial contamination when relevant. For research use, matching analytical records to a specific lot helps trace experimental variability.
Dihexa occupies an uncertain regulatory space in many countries. It is not generally listed as an approved therapeutic, and some jurisdictions may treat it as a research chemical, a compounded substance, or an unapproved new drug depending on claims and distribution. Importation can be restricted, and suppliers may require documentation that the material is for laboratory research only. Quality and labeling vary, so buyers should request analytical data, verify lot numbers, and understand local rules. These factors make sourcing and compliance part of the practical context around dihexa.
Lyophilized dihexa is typically stored as a dry powder at or below minus twenty degrees Celsius. Cooler temperatures slow degradation, and desiccant protection limits moisture uptake. Repeated temperature cycling can accelerate breakdown, so aliquoting before storage is common in laboratory practice. Solutions are generally less stable than dry powder and are often kept cold, protected from light, and used within a defined period. Specific stability data for dihexa are limited, and handling recommendations often follow general peptide guidelines rather than compound-specific studies.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C or lower | For lyophilized powder; avoid repeated freeze-thaw. |
| Appearance | White to off-white powder | Common for lyophilized peptides. |
| Solubility | Soluble in water and aqueous buffers | Limited solubility in nonpolar solvents. |
| Typical analytical method | Reverse-phase HPLC and mass spectrometry | Used for purity and identity checks. |
| Typical purity specification | 95% or greater by HPLC area | Supplier values vary; not a biological potency measure. |
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
The compound has been examined in animal models for effects on learning, memory, and synaptic connectivity. Some reports describe increased dendritic spine density and improved performance on certain behavioral tasks after administration in rodents. These findings are often cited in discussions of nootropic research peptides, but replication across independent laboratories remains limited. The absence of published phase 1 or phase 2 clinical trial data makes it difficult to assess safety, effective routes, or long-term outcomes in humans. Consequently, claims about cognitive benefits in people remain speculative.
Dihexa is not approved as a medicine in major regulatory jurisdictions. It is commonly sold as a research chemical for laboratory use, though such products may not be standardized or independently verified. Scientific literature on dihexa includes in vitro assays, rodent studies, and reviews that discuss its proposed mechanism. The distinction between peer-reviewed findings and commercial promotion is important when evaluating available information. Open questions include its precise binding interactions, pharmacokinetics, and whether animal results translate to human biology.
Regulatory and commercial contexts differ from clinical medicine. Dihexa is not approved as a drug by major agencies, and no published human trials establish its safety or efficacy. It is often sold as a research chemical labeled for laboratory use only. Suppliers may provide certificates of analysis, but purity and identity depend on the specific batch. Legal status varies by country and may treat such compounds as unapproved substances for human consumption.
Dihexa is a synthetic peptidomimetic derived from angiotensin IV, a naturally occurring peptide fragment. It was created as a research compound to explore central nervous system signaling rather than as an approved therapeutic. Early work described it as a small, orally available molecule in rodent studies. Its structure combines tyrosine, isoleucine, and aminohexanoic acid components with a hexanoic acid cap. The compound is commonly referred to by the research code PNB-0408.
Development of dihexa followed from studies on angiotensin IV analogs and their effects on learning and memory. Researchers sought compounds with improved metabolic stability and brain penetration compared with natural peptides. In preclinical reports, dihexa was associated with changes in synaptic connectivity and performance on spatial tasks. These findings generated interest in its potential as a cognitive research tool. The work remains largely preclinical, and independent replication has been limited.
Quality control usually combines reverse-phase high-performance liquid chromatography with mass spectrometry. Chromatography estimates purity and detects related impurities, while mass spectrometry supports molecular identity. Nuclear magnetic resonance can provide additional structural confirmation when needed. Stability data for dihexa are limited, and degradation pathways may depend on pH, temperature, and moisture. Open questions include long-term stability in different formulations and the effect of repeated freeze-thaw cycles on measured purity. Such tests help confirm that a batch matches its label before use.
In laboratory settings, dihexa is typically handled as a lyophilized peptide powder. Appropriate personal protective equipment and a ventilated workspace are standard practices for weighing and transferring research chemicals. Because the compound lacks regulatory approval for clinical use, it should not be given to people. Institutional safety rules and local regulations govern its acquisition, storage, and disposal. Suppliers often provide a certificate of analysis that lists purity, identity, and batch-specific handling notes.
The properties of many polymers are affected by hydrogen bonds within and/or between the chains. Prominent examples include cellulose and its derived fibers, such as cotton and flax. In nylon, hydrogen bonds between carbonyl and the amide NH effectively link adjacent chains, which gives the material mechanical strength. Hydrogen bonds also affect the aramid fibre, where hydrogen bonds stabilize the linear chains laterally. The chain axes are aligned along the fibre axis, making the fibres extremely stiff and strong. Hydrogen-bond networks make both polymers sensitive to humidity levels in the atmosphere because water molecules can diffuse into the surface and disrupt the network. Some polymers are more sensitive than others. Thus nylons are more sensitive than aramids, and nylon 6 more sensitive than nylon-11.
The company is working with food supplier Warabeya Nichiyo, which already supplies 7-Eleven's commissary food offerings in Japan, to create a US supply chain that will bring higher-quality Western and Japanese food offerings to 7-Eleven stores. Isaka also announced 7-Eleven's plan to grow its footprint and consolidate a larger portion of the US convenience store market. The company announced plans to add hot and cold food options and a larger baked goods selection at up to 1,600 Speedway and Stripes stores. Fuel In the U.S., many 7-Eleven filling stations had gasoline distributed by Citgo, which in 1983 were purchased by Southland Corporation. 50% of Citgo was sold in 1986 to Petróleos de Venezuela, S.A., and the remaining 50% was acquired in 1990. Although Citgo was the predominant partner of 7-Eleven, other oil companies are also co-branded with 7-Eleven, including Fina, Exxon, Mobil, Gulf, Marathon, BP, Amoco, Phillips 66, Conoco, 76, Shell, Chevron (some former TETCO convenience stores were co-branded with Chevron, and Texaco prior to the 7-Eleven purchase in late 2012), Sunoco, and Sinclair. Conoco is the largest 7-Eleven licensee in North America. The Pittsburgh market alone—where 7-Eleven is the market leader by store count but third behind Sheetz and GetGo in revenue— offers fuel from Exxon, Gulf, Marathon (both legacy 7-Eleven locations and Speedway), BP, and Sunoco (the latter two being from 7-Eleven's acquisitions of their company-owned-and-operated locations in the area) and also having previously offered Citgo and Pennzoil at some locations.
Under Lenin, the state made explicit commitments to promote the equality of men and women. Many early Russian feminists and ordinary Russian working women actively participated in the Revolution, and many more were affected by the events of that period and the new policies. Beginning in October 1918, Lenin's government liberalized divorce and abortion laws, decriminalized homosexuality (re-criminalized in 1932), permitted cohabitation, and ushered in a host of reforms. However, without birth control, the new system produced many broken marriages, as well as countless out-of-wedlock children. The epidemic of divorces and extramarital affairs created social hardships when Soviet leaders wanted people to concentrate their efforts on growing the economy. Giving women control over their fertility also led to a precipitous decline in the birth rate, perceived as a threat to their country's military power. By 1936, Stalin reversed most of the liberal laws, ushering in a pronatalist era that lasted for decades. By 1917, Russia became the first great power to grant women the right to vote. After heavy casualties in World Wars I and II, women outnumbered men in Russia by a 4:3 ratio; this contributed to the larger role women played in Russian society compared to other great powers at the time.
Sources: en.wikipedia.org
Great strides were made, however, in the areas of employment (which became nearly full), universal public education (which nearly eradicated adult illiteracy), health care and recreational amenities. Many historic sites, including the central districts of Warsaw and Gdańsk, both devastated during the war, were rebuilt at great cost. The communist industrialization program led to increased urbanization and educational and career opportunities for the intended beneficiaries of the social transformation, along the lines of the peasants-workers-working intelligentsia paradigm. The most significant improvement was accomplished in the lives of Polish peasants, many of whom were able to leave their impoverished and overcrowded village communities for better conditions in urban centers. Those who stayed behind took advantage of the implementation of the 1944 land reform decree of the Polish Committee of National Liberation, which terminated the antiquated but widespread parafeudal socioeconomic relations in Poland. The Stalinist attempts at establishing collective farms generally failed. Due to urbanization, the national percentage of the rural population decreased in communist Poland by about 50%. A majority of Poland's residents of cities and towns still live in apartment blocks built during the communist era, in part to accommodate migrants from rural areas.
=== Structure === Veratridine is a derivative, the 3-veratroate ester, of veracevine, which belongs to the class of C-nor-D-homosteroidal alkaloids. The molecular structure and stereochemistry of this and related alkaloids were only established after decades of chemical investigations. The structure of veratridine has been confirmed by NMR spectroscopy and X-ray crystallography. Veratridine displays an unusual steroidal backbone. In the typical four-ring nucleus with three six-membered rings and one five-membered ring (like the one in cholesterol), the five-membered ring is on the end. Veratridine, and other Veratrum alkaloids, have the five-membered ring between the second and third six-membered rings. The benzene ring of veratridine can be derivatized under relatively mild reaction conditions, allowing late stage functionalization of the toxin.
In February 2025, the firm announced a historic multi-year renewal of its long-term partnership with the Ultimate Fighting Championship, marking the largest sponsorship deal in the history of both companies. Several UFC champions have partnered with Monster Energy, including Conor McGregor, Justin Gaethje, Cain Velasquez, and Jon "Bones" Jones. In November 2012, the firm announced a long-term partnership with the Professional Bull Riders, and currently sponsors several riders including Jose Vitor Leme, Cody Teel, and Derek Kolbaba. Starting in 2018, they became the title sponsor of the PBR's premiership tour, known as the Unleash the Beast tour.
Sources: en.wikipedia.org
The lyophilized powder is commonly kept at -20 °C or lower, protected from moisture and light. Solutions may require colder storage and should avoid repeated freeze-thaw cycles. General peptide stability practices apply.
Reverse-phase HPLC can estimate purity, while mass spectrometry helps confirm molecular mass. These methods do not prove biological effects. Lot-specific certificates may provide additional data.
It is not an approved medicine in major jurisdictions. Depending on the country and marketing claims, it may be treated as a research chemical or unapproved substance. Import and sale rules vary.
Dihexa has been proposed to act through HGF and c-Met signaling. This pathway is linked to synapse formation and cellular growth. Direct binding and the precise molecular step remain uncertain.